Elevation Oncology Inc (ELEV) Return on Investment ROI from the first quarter of 2025 to first quarter of 2024 and for the year 2025, average high and low, overall ranking from Mar 31 2025 to Mar 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Elevation Oncology inc   (NASDAQ: ELEV)


Elevation Oncology Inc's ROI from its first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Elevation Oncology Inc's ROI in the first quarter of 2025?
Elevation Oncology Inc recorded a cumulative net loss of $-48 million during 12 months ending in the first quarter of 2025, resulting in a negative return on investment (ROI) of -50.34%.

Within the Healthcare sector 519 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2024 from 2778 to 3598.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter
Y / Y Investment Change TTM -1.18 % 19.66 % 20.12 % 16.34 % 12.53 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 78 91 100 112 107
Return On Investment (TTM) -50.34 % -43.4 % -41.55 % -40.13 % -40.79 %
ELEV's Overall Ranking # 3598 # 2778 # 3518 # 1373 # 1125
Seq. Investment Change TTM -6.99 % 1.54 % 2.02 % 2.56 % 12.63 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -48 -44 -42 -40 -39

ELEV Company Profile >> Back to ELEV Roi Comparisons >> See Annual ELEV Return On Investment



Return On Investment ELEV's Ranking
Within: No.
Industry # 77
Sector # 520
Overall # 3598

Return On Investment Statistics
High Average Low
-12.13 %
-53.04 %
-110.66 %
(Mar 31 2022)   (Mar 31 2023)







Financial Statements
Elevation Oncology Inc's I. Quarter Investments $ 78 Millions ELEV's Balance sheet
Elevation Oncology Inc's I. Quarter Income $ -14 Millions Quarterly ELEV's Income Statement
ELEV's Income by Division See ELEV's Income by Division


ELEV Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 91 85 78 141 0
Y / Y Investment Growth 7.31 % 8.25 % -44.23 % - -
Net Income in Millions -44 -46 -95 -32 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -48.8 % -53.8 % -121.17 % -22.77 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ELEV's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ELEV's Competitors
Subscribers only: Roi for Elevation Oncology Inc's Suppliers
Subscribers only: Return On Investment for ELEV's Customers

Other Ratios
ELEV's Roa ELEV's Inventory Turnover Ratio ELEV's Growth Rates ELEV's Dividend Statistics
ELEV's Profitability Ratios ELEV's Asset Turnover Ratio ELEV's Dividend Growth
ELEV's Roe ELEV's Valuation Ratios ELEV's Financial Strength Ratios ELEV's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2025, within Healthcare Sector ROI

Date modified: 2026-10-05T11:03:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.